WASHINGTON — Sen. Bill Cassidy (La.), a key Republican senator with seats on the chamber’s health and finance committees, ...

STAT's podcast The Readout LOUD this week discusses cannabinoid receptor drugs in weight loss, what the Fed's rates cut might ...

FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...

A Senate committee voted to hold Ralph de la Torre, CEO of troubled Steward Health Care, in contempt. If the full Senate ...

As for Amazon, it’s staying true to it’s legacy as an online store. Invitations described the event as an opportunity to ...

The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally.

Vonda Vaden Bates’ husband “might have survived if we had not confused kindness with skilled, quality care,” she writes.

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Why Corbus Pharmaceuticals sees Novo Nordisk’s controversial approach to obesity drugs as a ticket to a blockbuster.